CAUSEWAY CAPITAL MANAGEMENT LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 870 filers reported holding NOVARTIS A G in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.

Quarter-by-quarter ownership
CAUSEWAY CAPITAL MANAGEMENT LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$19,049,777
-16.3%
187,019
-17.1%
0.50%
-16.0%
Q2 2023$22,760,016
+0.7%
225,548
-8.2%
0.60%
+10.5%
Q1 2023$22,605,078
+11.8%
245,707
+10.3%
0.54%
-7.7%
Q4 2022$20,215,338
-1.8%
222,832
-17.7%
0.59%
+1.7%
Q3 2022$20,586,000
-22.0%
270,830
-13.3%
0.58%
-12.4%
Q2 2022$26,402,000
-23.2%
312,341
-20.3%
0.66%
-19.8%
Q1 2022$34,377,000
+2.9%
391,762
+2.6%
0.82%
+11.8%
Q4 2021$33,411,000
+1.9%
381,967
-4.8%
0.74%
-0.4%
Q3 2021$32,803,000
-15.8%
401,116
-6.1%
0.74%
-7.2%
Q2 2021$38,958,000
+14.7%
426,982
+7.5%
0.80%
+19.0%
Q1 2021$33,966,000
+17.7%
397,358
+30.0%
0.67%
+23.0%
Q4 2020$28,856,000
+5.3%
305,578
-3.0%
0.54%
+6.5%
Q3 2020$27,394,000
-3.8%
315,018
-3.4%
0.51%
-0.6%
Q2 2020$28,489,000
+5.8%
326,186
-0.2%
0.51%
+19.3%
Q1 2020$26,939,000
-3.2%
326,734
+11.2%
0.43%
+43.8%
Q4 2019$27,829,000
+24.2%
293,899
+14.0%
0.30%
+11.6%
Q3 2019$22,407,000
-11.5%
257,850
-7.0%
0.27%
-3.2%
Q2 2019$25,324,000
-6.8%
277,339
-1.9%
0.28%
+0.7%
Q1 2019$27,182,000
+8.2%
282,730
-3.4%
0.28%
-8.0%
Q4 2018$25,124,000
-35.2%
292,788
-35.0%
0.30%
-23.3%
Q3 2018$38,783,000
+11.1%
450,132
-2.6%
0.39%
+10.5%
Q2 2018$34,897,000
+5.0%
461,962
+12.4%
0.35%
-0.8%
Q1 2018$33,236,000
+17.2%
411,077
+21.7%
0.36%
+18.3%
Q4 2017$28,357,000
+6.4%
337,742
+8.8%
0.30%
+0.7%
Q3 2017$26,658,000
-13.5%
310,514
-15.9%
0.30%
-21.7%
Q2 2017$30,801,000
+22.6%
369,006
+9.1%
0.38%
+12.4%
Q1 2017$25,114,000
+11.3%
338,149
+6.3%
0.34%
-13.9%
Q4 2016$22,560,000
-11.1%
318,018
-1.0%
0.40%
-15.2%
Q3 2016$25,367,000
-3.7%
321,258
+0.6%
0.47%
-16.9%
Q2 2016$26,350,000
+9.6%
319,351
+0.9%
0.56%
+1.4%
Q1 2016$24,034,000
-0.8%
316,362
+12.3%
0.55%
+7.8%
Q4 2015$24,238,000
+0.4%
281,710
+7.3%
0.51%
+5.8%
Q3 2015$24,144,000
+3.7%
262,666
+11.0%
0.48%
-16.7%
Q2 2015$23,278,000
+6.0%
236,714
+6.3%
0.58%
+1.6%
Q1 2015$21,956,000
-29.5%
222,652
-33.8%
0.57%
-36.3%
Q4 2014$31,160,000
-0.9%
336,278
+0.6%
0.90%
-17.5%
Q3 2014$31,456,000
+12.8%
334,171
+4.2%
1.09%
-4.2%
Q2 2014$27,895,000
+0.2%
320,852
-2.0%
1.14%
-9.0%
Q1 2014$27,831,000
+22.9%
327,343
+16.2%
1.25%
-2.5%
Q4 2013$22,646,000
+311.2%
281,741
+292.4%
1.28%
+186.0%
Q3 2013$5,507,000
+32.2%
71,794
+21.9%
0.45%
+2.3%
Q2 2013$4,165,00058,9090.44%
Other shareholders
NOVARTIS A G shareholders Q1 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders